Anti-Tumor Effect of a Novel Soluble Recombinant Human Endostatin: Administered as a Single Agent or in Combination with Chemotherapy Agents in Mouse Tumor Models

• Zhihua Ren ,

  Contributed equally to this work with: Zhihua Ren, Yanan Wang

  Affiliations Biopharmagen Corp., Suzhou, China, Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China

  ⨯
• Yanan Wang ,

  Contributed equally to this work with: Zhihua Ren, Yanan Wang

  Affiliation Department of Laboratory Diagnosis, Suzhou Municipal Hospital Affiliated Nanjing Medical University, Suzhou, China

  ⨯
• Wenhong Jiang,

  Affiliation Biopharmagen Corp., Suzhou, China

  ⨯
• Wei Dai ,

  * E-mail: wei.dai@nyumc.org (WD); yjiang@biopharmagen.com (YK)

  Affiliations Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China, Department of Environmental Medicine, New York University Langone Medical Center, Tuxedo, New York, United States of America

  ⨯
• Yongping Jiang

  * E-mail: wei.dai@nyumc.org (WD); yjiang@biopharmagen.com (YK)

  Affiliations Biopharmagen Corp., Suzhou, China, Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China

  ⨯